| Smith, Christopher P |
NCT04318548 / 2016-003722-16: Study to Assess the Safety and Immunogenicity of GSK Meningococcal Group B Vaccine When Administered Concomitantly With GSK Meningococcal MenACWY Conjugate Vaccine in Healthy Subjects of 16-18 Years of Age |
|
|
| Active, not recruiting | 3 | 943 | Europe, US | Meningococcal Group B Vaccine (GSK3536829A) (rMenB+OMV NZ), Bexsero, Meningococcal MenACWY Conjugate Vaccine (GSK3536820A) (MenA lyo + MenCWY liquid), Menveo, Placebo, NaCl, saline solution | GlaxoSmithKline | Infections, Meningococcal | 11/23 | 07/24 | | |
| Recruiting | 3 | 450 | US | LY3650150, Placebo, Standard therapy for INCS | Eli Lilly and Company | Perennial Allergic Rhinitis (PAR) | 05/25 | 05/26 | | |
| Recruiting | 3 | 1700 | Europe, Canada, Japan, US, RoW | GSK3511294 (Depemokimab), Mepolizumab, Benralizumab, Placebo, Standard of care (SoC), Pre-filled Syringes (PFS) | GlaxoSmithKline, Iqvia Pty Ltd | Asthma | 09/25 | 09/25 | | |
|
NCT05468736: Study to Evaluate Safety and Immunogenicity of COVID-19 Vaccine in Children 6 Months to < 12 Years |
|
|
| Active, not recruiting | 2/3 | 3600 | Europe, US, RoW | Biological/Vaccine: SARS-CoV-2 rS/Matrix-M1 Adjuvant (Initial Vaccination Period), NVX-CoV2373, SARS-CoV-2 rS/Matrix-M1 Adjuvant (Open Label Crossover Vaccination period), SARS-CoV-2 rS/Matrix-M1 Adjuvant (Booster Vaccination), Placebo, Sodium chloride 0.9% (BP, sterile) | Novavax | COVID-19 | 11/23 | 09/25 | | |
CALM-CSU, NCT06077773: Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of EP262 in Subjects With Chronic Spontaneous Urticaria |
|
|
| Recruiting | 2 | 114 | Europe, Canada, US | Oral EP262, Placebo | Escient Pharmaceuticals, Inc | Chronic Spontaneous Urticaria | 01/25 | 02/25 | | |
NCT02839915: Leucovorin for the Treatment of Language Impairment in Children With Autism Spectrum Disorder |
|
|
| Active, not recruiting | 2 | 56 | US | Folinic Acid, Liquid levo-leucovorin, Placebo | Southwest Autism Research & Resource Center, Emory University, Harvard University, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), State University of New York - Downstate Medical Center | Autism Spectrum Disorder | 04/24 | 01/25 | | |
NCT04060017: Early Treatment of Language Impairment in Young Children With Autism Spectrum Disorder With Leucovorin Calcium |
|
|
| Recruiting | 2 | 80 | US | Levoleucovorin Calcium, L-leucovorin, L-leucovorin calcium, L-folinic acid, calcium salt, L-folinate, calcium salt, Placebo | Southwest Autism Research & Resource Center, State University of New York - Downstate Medical Center, United States Department of Defense | Autism Spectrum Disorder, Language Disorders | 01/25 | 01/25 | | |
NCT04060030: Treatment of Social and Language Deficits With Leucovorin for Young Children With Autism |
|
|
| Recruiting | 2 | 80 | US | Levoleucovorin Calcium, L-leucovorin, L-leucovorin calcium, L-folinic acid, calcium salt, L-folinate, calcium salt, Placebo | Southwest Autism Research & Resource Center, Autism Speaks, State University of New York - Downstate Medical Center | Autism Spectrum Disorder, Language Disorders | 01/25 | 01/25 | | |
NCT05081245: ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD) |
|
|
| Recruiting | 2 | 150 | Canada, US, RoW | ML-004 (IR)/(ER) tablet, ML-004 Placebo | MapLight Therapeutics | Autism Spectrum Disorder | 03/25 | 04/25 | | |
| Not yet recruiting | 1 | 10 | US | TBC | Uro-Research, LLC | Spinal Cord Injury (SCI), Chronic Urinary Retention, Urinary Incontinence | 12/20 | 12/22 | | |
NCT05062902: A Novel Medical System for Quantitative Diagnosis and Personalized Precision Botulinum Neurotoxin Injection in Chronic Pelvic Pain Management |
|
|
| Not yet recruiting | 1 | 46 | US | High Density Surface Electromyographic, precision botulinum neurotoxin injection guidance medical device, Botulinum Neurotoxin | HillMed Inc., Baylor College of Medicine, University of Houston | Interstitial Cystitis, Chronic Pain, Pelvic Floor; Relaxation, Pelvic Floor Disorders | 12/27 | 12/27 | | |
| Not yet recruiting | N/A | 20 | Europe | Hemiarthroplasty, Total elbow arthroplasty | Royal Devon and Exeter NHS Foundation Trust | Distal Humerus Fracture | 05/23 | 11/23 | | |
NCT06334718: Drone Delivered Defibrillators (The 3D Project). |
|
|
| Recruiting | N/A | 44 | Europe | Interviews and simulation | University of Warwick, Welsh Ambulance Service NHS Trust | Cardiac Arrest, Out-Of-Hospital | 08/24 | 10/24 | | |
NCT06354920: M-Well Bonding Bundle to Improve Patient-Physician Relationships |
|
|
| Recruiting | N/A | 3624 | US | Bonding Bundle | University of Michigan, Agency for Healthcare Research and Quality (AHRQ) | Physician-Patient Relations | 06/26 | 06/26 | | |
| Recruiting | N/A | 332 | US | Assessment by Expert Clinician During Behavioral Intervention (ABA or similar), Applied Behavior Analysis, Assessment by the EarliPoint Assessment For Autism Spectrum Disorder, EarliPoint System: Assessment for Autism Spectrum Disorder | EarliTec Diagnostics, Inc, Marcus Autism Center | Autism Spectrum Disorder, Autism, Developmental Delay, Autism, Early Infantile, Autism, Infantile | 09/24 | 09/24 | | |
| Recruiting | N/A | 80 | Europe | Salmonella Typhimurium | Imperial College Healthcare NHS Trust, University of Oxford, University of Liverpool, PATH, Imperial College London | Salmonella Infections, Salmonella Typhimurium, Non-typhoidal Salmonella (NTS), Invasive Non-Typhoidal Salmonella Disease, Communicable Disease, Infections, Bacterial, Enteric Fever (Not Typhoid), Gastroenteritis | 09/24 | 06/25 | | |
MEASURE-ASD2, NCT05806216: Dynamic Quantification of Social-Visual Engagement in Autism Spectrum Disorder (ASD) For Children Ages 31-84 Months |
|
|
| Recruiting | N/A | 790 | US | EarliPoint Diagnosis, EarliPoint, Clinically Certain Expert Clinician Diagnosis (CC-ECD), CC-ECD | EarliTec Diagnostics, Inc, Marcus Autism Center | Autism Spectrum Disorder, Autism | 03/25 | 03/25 | | |
RECIPE, NCT05685433: A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation |
|
|
| Recruiting | N/A | 200 | US | eCoin Tibial Nerve Stimulation | Valencia Technologies Corporation | Overactive Bladder, Urge Incontinence, Incontinence, Urinary, Urinary Urge Incontinence | 08/25 | 12/30 | | |
NCT04322734: Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders |
|
|
| Not yet recruiting | N/A | 500 | US | | Southwest Autism Research & Resource Center, State University of New York - Downstate Medical Center | Autism Spectrum Disorder, Mitochondrial Pathology, Epilepsy, Brain Tumor, Psychiatric Disorder, Mitochondrial Diseases | 01/26 | 01/26 | | |
| Kandel, Christopher |
| Recruiting | 4 | 8000 | Europe, Canada, RoW | Cefazolin, Penicillin, Benzylpenicillin, Penicillin G, Clindamycin, Lincomycin, Vancomycin, Daptomycin, Effectiveness of early switch to oral antibiotics, Whole body FDG PET/CT Imaging | University of Melbourne, Berry Consultants, McGill University Health Centre/Research Institute of the McGill University Health Centre, Menzies School of Health Research, Aotearoa Clinical Trials, Queensland University of Technology, Sunnybrook Health Sciences Centre, Tan Tock Seng Hospital, Telethon Kids Institute, The Peter Doherty Institute for Infection and Immunity, The University of Queensland, UMC Utrecht, Radboud University Medical Center, King's College London, Rambam Health Care Campus, University College, London, Houston Medical Research Institute | Staphylococcus Aureus Bacteremia | 12/28 | 12/28 | | |
TAPER-V, NCT04138706: Initial Vancomycin Taper for the Prevention of Recurrent Clostridium Difficile Infection |
|
|
| Recruiting | 3 | 552 | Canada | Vancomycin, Placebos | McGill University Health Centre/Research Institute of the McGill University Health Centre, Canadian Institutes of Health Research (CIHR) | Clostridium Difficile Infection | 07/24 | 09/24 | | |
| Active, not recruiting | 3 | 2900 | Canada | Artesunate, Imatinib, Infliximab, Dexamethasone, LSALT Peptide | Sunnybrook Health Sciences Centre, AbbVie, Apotex Inc., World Health Organization, University of British Columbia, Arch Biopartners Inc. | COVID-19 | 03/24 | 05/24 | | |
| Completed | 2 | 157 | Canada, RoW | Peginterferon Lambda-1A, placebo | University Health Network, Toronto, Michael Garron Hospital | Sars-CoV2, Covid-19 | 08/22 | 12/22 | | |
| Recruiting | N/A | 346 | Canada | Simplified layered consent form, Full-length consent form | Sunnybrook Health Sciences Centre, McGill University Health Centre/Research Institute of the McGill University Health Centre | Staphylococcus Aureus Bacteremia | 06/25 | 06/25 | | |
| Recruiting | N/A | 72 | Canada | De-escalation VS No De-escalation, Oral beta-lactams VS non beta-lactams, Central vascular catheter retention VS Central vascular catheter replacement, Cephalosporin VS Carbapenem for low risk AmpC organisms, Routine follow-up blood culture VS No routine follow-up blood culture | Sunnybrook Health Sciences Centre, Canadian Institutes of Health Research (CIHR) | Gram-negative Bacteremia | 06/27 | 07/27 | | |
| MoinSadat, Hoda |
| No trials found |
